Call for Papers: 6-Journal Virtual Special Issue on Epigenetics - ACS Axial | ACS Publications
Search
Close

Call for Papers: 6-Journal Virtual Special Issue on Epigenetics

ACS Chemical Biology, ACS Chemical Neuroscience, ACS Infectious Diseases, ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry invite the biomedical research community to submit manuscripts for a 2022 joint virtual special issue on advances in epigenetics.

This joint virtual special issue is a follow-up to a highly read and well-cited joint special issue on the same topic published in 2016 by ACS Chemical Biology, ACS Medicinal Chemistry Letters, Biochemistry, and the Journal of Medicinal Chemistry.

The issue will highlight the broad spectrum of research pursuits and accomplishments in this exciting area of study. Each journal will focus on a different aspect of epigenetics and will have its contribution led by selected guest editors.

Each manuscript will first be published in a regular issue shortly after it is accepted for publication. Once all papers have been accepted, they will be collected on a single webpage, giving additional exposure to each author’s work. This website will be announced in another regular issue that includes an introductory Editorial by the guest editors.

Read on to learn more about what types of manuscripts each participating journal is seeking and see the submission deadlines.

ACS Chemical Biology

Submission Deadline: December 1, 2021

Guest Editor: Jordan Meier, (US) National Cancer Institute

ACS Chemical Biology welcomes submissions that use chemical biology approaches or describe new chemical biology tools to understand or exploit epigenetic mechanisms or functions.

Please select the “Epigenetics 2022” tag in the Special Issue dropdown menu during submission to mark your manuscript for consideration for inclusion in the issue. Please note that all submissions will undergo the standard peer-review process.

We look forward to reading about your latest research developments, and thank you for supporting our journal and the chemical biology research community!

LEARN MORE: Read ACS Chemical Biology’s call for papers Editorial

If you have questions, please email ed-office@chembio.acs.org.

ACS Chemical Neuroscience

Submission Deadline: November 1, 2021

Guest Editor: Stephan J. Haggarty, Harvard Medical School, Massachusetts General Hospital, Broad Institute of MIT & Harvard

ACS Chemical Neuroscience will focus on epigenetic mechanisms associated with neurogenesis, neural plasticity, as well as cognition and memory. Papers of interest also include those aimed at neuropsychiatric disorders for which epigenetic deregulation is a key driver of the disease phenotype. Articles, letters, perspectives, and reviews are all welcome.

Please tag your manuscript by selecting “Epigenetics 2022” from the Special Issue dropdown menu during submission.

We look forward to reading about your latest research developments, and thank you for supporting our journal and the chemical neuroscience research community!

If you have questions, please email eic@chemneuro.acs.org.

ACS Infectious Diseases

Submission Deadline: December 31, 2021

Guest Editors: Associate Editor Félix Calderón, GlaxoSmithKline; Kelly Chibale, University of Cape Town; and Nathaniel G. Jones, University of York;

ACS Infectious Diseases invites the submission of Articles, Letters, Reviews, Viewpoints, and Perspectives from academic groups, nonprofits, and industry. Recognizing the breadth of research that can be encompassed in the theme “epigenetics,” we are reflecting this with a wide scope of interest. This includes work on genetic and chemical target validation of pathogen histone-modifying enzymes, reader proteins of these modifications, targeting of the host response to pathogens, pathogen virulence factors that impact human epigenetic processes, host-pathogen interactions, epi-transcriptomics, platforms for drug discovery, experimental model systems, mechanistic characterizations, approaches utilizing biologicals, natural products, and synthetic small molecules. We are open to works detailing the biology of viral, bacterial, and eukaryotic pathogens.

LEARN MORE: Read ACS Infectious Diseases’ call for papers Editorial

If you have questions, please email eic@id.acs.org.

ACS Medicinal Chemistry Letters

Submission Deadline: December 31, 2021

Guest Editors: Robert A. Copeland, Accent Therapeutics, Inc., and Associate Editor Donna M. Huryn, University of Pittsburgh

ACS Medicinal Chemistry Letters invites Notes, Letters, Innovations, and Technology Notes manuscripts that advance our understanding of chemical modulators of chromatin- and RNA-modifications. We call upon scientists in medicinal chemistry and allied fields to contribute their research and innovations to this special issue of the journal.

LEARN MORE: Read ACS Medicinal Chemistry Letters’ call for papers Editorial

If you have questions, please email eic@medchemlett.acs.org.

ACS Pharmacology & Translational Science

Submission Deadline: December 31, 2021

Guest Editors: Sanil Bhatia,Heinrich-Heine University Düsseldorf; Finn K. Hansen, University of Bonn; and Matthias Schiedel, Friedrich-Alexander-Universität Erlangen-Nürnberg

ACS Pharmacology & Translational Science invites active researchers to submit manuscripts detailing recent advances in the field of epigenetics, including the development and recommendation of novel tool compounds for epigenetic targets and the discovery of new biomarkers.

LEARN MORE: Read ACS Pharmacology & Translational Science’s call for papers Editorial

If you have questions, please email eic@ptsci.acs.org.

Journal of Medicinal Chemistry

Submission Deadlines: July 31, 2021, for Perspectives; October 31, 2021, for Articles and Drug Annotations

The Journal of Medicinal Chemistry invites submissions across the full spectrum of epigenetics, including epigenetic studies focused on human and non-human species. The Journal of Medicinal Chemistry is traditionally associated with full-length papers that report substantial studies in medicinal chemistry, and we are keen to receive such submissions. However, we are also excited to receive shorter, more preliminary studies, which report work of high novelty. We would also like to encourage Perspectives and Drug Annotations in the epigenetics area.

LEARN MORE: Read the Journal of Medicinal Chemistry’s call for papers Editorial

Want more stories like this delivered to your inbox?

Sign up for our newsletter to receive a selection of stories related to your favorite topics.

  • This field is for validation purposes and should be left unchanged.